GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » PB Ratio

LifeTech Scientific (HKSE:01302) PB Ratio : 2.17 (As of May. 25, 2024)


View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-25), LifeTech Scientific's share price is HK$1.73. LifeTech Scientific's Book Value per Share for the quarter that ended in Dec. 2023 was HK$0.80. Hence, LifeTech Scientific's PB Ratio of today is 2.17.

Good Sign:

LifeTech Scientific Corp stock PB Ratio (=2.17) is close to 10-year low of 2

The historical rank and industry rank for LifeTech Scientific's PB Ratio or its related term are showing as below:

HKSE:01302' s PB Ratio Range Over the Past 10 Years
Min: 2   Med: 7.49   Max: 54.47
Current: 2.17

During the past 13 years, LifeTech Scientific's highest PB Ratio was 54.47. The lowest was 2.00. And the median was 7.49.

HKSE:01302's PB Ratio is ranked better than
51.65% of 790 companies
in the Medical Devices & Instruments industry
Industry Median: 2.23 vs HKSE:01302: 2.17

During the past 12 months, LifeTech Scientific's average Book Value Per Share Growth Rate was 13.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 9.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 22.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 34.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of LifeTech Scientific was 83.00% per year. The lowest was -16.60% per year. And the median was 27.25% per year.

Back to Basics: PB Ratio


LifeTech Scientific PB Ratio Historical Data

The historical data trend for LifeTech Scientific's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific PB Ratio Chart

LifeTech Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.02 7.42 5.53 3.69 2.95

LifeTech Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.53 4.40 3.69 3.49 2.95

Competitive Comparison of LifeTech Scientific's PB Ratio

For the Medical Devices subindustry, LifeTech Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's PB Ratio distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's PB Ratio falls into.



LifeTech Scientific PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

LifeTech Scientific's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=1.73/0.796
=2.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


LifeTech Scientific  (HKSE:01302) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


LifeTech Scientific PB Ratio Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific (HKSE:01302) Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.
Executives
Xie Yuehui 2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited 2101 Beneficial owner
Hhlr Advisors, Ltd. 2102 Investment manager
Bank Of Communications Trustee Limited 2301 Trustee
Xie Yuehui 2201 Interest of corporation controlled by you
Hhlr Fund, L.p. 2101 Beneficial owner
Hillhouse Capital Advisors, Ltd. 2102 Investment manager
Gaoling Fund, L.p. 2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines